You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GLUE Sale Disclosure
Champoux Jennifer · SEC Form 4 · Filed Jul 16, 2026
Sale
Calculated transaction value
$101.73K
Champoux Jennifer Chief Operating Officer
GLUE
Transaction date
Jul 15, 2026
Public filing date
Jul 16, 2026
Filing lag
Filed 1 day later
GLUE daily price context
Close on/before transaction
$23.41
Jul 15, 2026
First close after public filing
$24.56
Jul 17, 2026
30-day return after filing
-37.38%
Through Aug 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,351 shares @ $23.38
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-306110
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$119.05K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Monte Rosa Therapeutics, Inc. GLUE | Exercise | Jul 15, 2026 | $17.32K |
| Monte Rosa Therapeutics, Inc. GLUE Current | Sale | Jul 15, 2026 | $101.73K |
| Monte Rosa Therapeutics, Inc. GLUE | Exercise | Jul 15, 2026 | $0 |